1. Home
  2. TISI vs VYNE Comparison

TISI vs VYNE Comparison

Compare TISI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

HOLD

Current Price

$13.25

Market Cap

66.9M

ML Signal

HOLD

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.57

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TISI
VYNE
Founded
1973
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.9M
12.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TISI
VYNE
Price
$13.25
$0.57
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
21.0K
14.8M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$884,953,000.00
$524,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.67
P/E Ratio
N/A
N/A
Revenue Growth
3.73
6.29
52 Week Low
$11.12
$0.28
52 Week High
$24.25
$4.30

Technical Indicators

Market Signals
Indicator
TISI
VYNE
Relative Strength Index (RSI) 33.10 70.59
Support Level $14.50 $0.56
Resistance Level $15.19 $0.75
Average True Range (ATR) 0.88 0.05
MACD -0.18 0.02
Stochastic Oscillator 1.02 54.36

Price Performance

Historical Comparison
TISI
VYNE

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: